GC-MS/MS Analysis of Persistent Organic Pollutants in Small Volumes of Human Plasma

Significance of the Topic

Persistent organic pollutants (POPs) represent a class of environmental contaminants linked to chronic diseases. Their concentrations in human plasma often fall below the detection limits of untargeted mass spectrometry, necessitating highly sensitive and specific analytical methods. By enabling reliable measurement of low-abundance chemicals from small sample volumes, targeted GC-MS/MS approaches advance exposome research and improve our understanding of cumulative exposure risks.

Objectives and Study Overview

This technical overview describes the development and application of a targeted gas chromatography-tandem mass spectrometry (GC-MS/MS) method to quantify 67 POPs in 200 µL human plasma. The key goals were to minimize sample volume requirements, achieve low-pg/mL detection limits, and demonstrate precision and robustness for population studies.

Methodology and Instrumentation

• Sample preparation involved chemical denaturation and liquid–liquid extraction: 200 µL plasma was mixed with urea, propanol/water, methanol, and petroleum ether, followed by centrifugation.
• Cleanup utilized a Florisil column; analytes were eluted with methyl tert-butyl ether/petroleum ether, evaporated, and reconstituted.
• Instrumentation: Agilent 7890B GC coupled to an Agilent 7010A triple quadrupole MS in electron ionization MRM mode.
• Chromatographic conditions: HP-5ms Ultra Inert column (30 m × 250 µm, 0.25 µm); transfer line at 300 °C; source at 350 °C; nitrogen collision gas at 1.5 mL/min.
• Target panel comprised 67 POPs across six chemical classes (PAHs, DL-PCBs, PBDEs, OCPs, dioxins, furans), with one quantifier and one qualifier MRM transition per analyte and ^13C_12-DDT as internal standard.

Main Results and Discussion

• Instrument precision: internal standard area RSD averaged 3% (range 0.4–6.8%); retention time variability ±0.122 min.
• Detection limits reached as low as 5 pg/mL for select analytes using the 200 µL extraction volume.
• Reported LODs: 0.005–0.02 ng/mL for DL-PCBs, 0.05–0.15 ng/mL for OCPs, 0.0075–0.075 ng/mL for PBDEs; unpublished MDLs improved further.
• In real plasma samples, 27 target POPs were detected, demonstrating method suitability for population exposome profiling.

Benefits and Practical Applications

• Enables comprehensive quantification of trace-level POPs in limited plasma volumes, preserving valuable biobanked samples.
• Supports epidemiological and exposome studies by providing reliable exposure data for risk assessment of chronic diseases.

Future Trends and Potential Uses

• Further reduction of required sample volume to 100 µL or below to accommodate scarce clinical specimens.
• Integration with other omics platforms (metabolomics, proteomics) for multi-layer exposome characterization.
• Adaptation to alternative matrices such as saliva, urine, or breast milk for broader exposure monitoring.

Conclusion

The presented GC-MS/MS workflow achieves low-pg/mL detection of multiple POP classes from just 200 µL of plasma with excellent precision. This targeted method enhances exposomic analyses by enabling high-sensitivity exposure measurement in small-volume samples, facilitating comprehensive studies of environmental influences on human health.

References

1. Ivanisevic J, et al. Toward ‘Omic Scale Metabolite Profiling: A Dual Separation–Mass Spectrometry Approach for Coverage of Lipid and Central Carbon Metabolism. Anal Chem. 2013;85(14):6876–6884.
2. Smith MT, de la Rosa R, Daniels SI. Using exposomics to assess cumulative risks and promote health. Environ Mol Mutagen. 2015;56(9):715–723.
3. Rappaport SM, Smith MT. Environment and disease risks. Science. 2010;330:460–461.
4. Rappaport SM, et al. The Blood Exposome and Its Role in Discovering Causes of Disease. Environ Health Perspect. 2014;122(8):769–774.